Go Pro

Vera Bradley (VRA) Financials

Vera Bradley logo
$4.01 +0.22 (+5.80%)
Closing price 07/15/2026 04:00 PM Eastern
Extended Trading
$4.04 +0.04 (+0.87%)
As of 06:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Vera Bradley

Annual Income Statements for Vera Bradley

This table shows Vera Bradley's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
28 20 7.02 21 16 8.68 18 -60 7.84 -62 -48
Consolidated Net Income / (Loss)
28 20 7.02 21 15 11 20 -79 8.60 -33 -33
Net Income / (Loss) Continuing Operations
28 20 7.02 21 15 11 20 -79 8.60 -33 -33
Total Pre-Tax Income
46 28 15 28 21 12 27 -95 12 -28 -32
Total Operating Income
47 28 15 27 19 13 27 -95 12 -29 -32
Total Gross Profit
281 276 254 239 272 266 288 239 204 159 125
Total Revenue
503 486 455 416 495 468 540 500 384 319 270
Operating Revenue
503 486 455 416 495 468 540 500 384 319 270
Total Cost of Revenue
221 210 201 178 223 203 253 261 180 160 145
Operating Cost of Revenue
221 210 201 178 223 203 253 261 180 160 145
Total Operating Expenses
234 248 239 211 252 252 261 334 192 188 157
Selling, General & Admin Expense
237 249 240 212 253 253 262 265 193 188 158
Other Operating Expenses / (Income)
-2.37 -1.33 -0.78 -0.50 -1.10 -0.14 -0.96 -0.46 -0.90 -0.83 -1.19
Total Other Income / (Expense), net
-0.26 -0.18 0.41 1.13 1.09 -1.20 -0.26 -0.15 0.66 0.75 -0.46
Interest Expense
0.26 0.18 -0.41 -1.13 -1.09 1.20 0.26 0.15 -0.66 -0.75 0.46
Income Tax Expense
19 8.28 8.38 7.47 5.32 1.17 6.43 -16 3.68 5.34 0.30
Basic Earnings per Share
$0.71 $0.54 $0.20 $0.59 $0.47 $0.26 $0.53 ($1.90) $0.25 ($2.15) ($1.71)
Weighted Average Basic Shares Outstanding
38.80M 36.84M 35.93M 35.22M 33.98M 33.39M 33.79M 31.50M 30.83M 28.94M 27.90M
Diluted Earnings per Share
$0.71 $0.53 $0.19 $0.59 $0.47 $0.26 $0.52 ($1.90) $0.25 ($2.15) ($1.71)
Weighted Average Diluted Shares Outstanding
38.86M 36.97M 36.03M 35.47M 34.29M 33.91M 34.44M 31.50M 31.31M 28.94M 27.90M
Weighted Average Basic & Diluted Shares Outstanding
38.80M 36.60M 35.10M 34.16M 33.12M 33.41M 32.52M 30.69M 30.79M 27.70M 27.97M

Quarterly Income Statements for Vera Bradley

This table shows Vera Bradley's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
Net Income / (Loss) Attributable to Common Shareholders
5.12 -1.86 -8.12 5.71 -13 -47 -33 -4.67 -12 2.66 -4.83
Consolidated Net Income / (Loss)
5.12 -1.86 -7.60 7.53 -13 -47 -18 -4.71 -12 2.66 -4.83
Net Income / (Loss) Continuing Operations
5.12 -1.86 -7.60 7.53 -13 -47 -18 -4.71 -12 2.66 -4.83
Total Pre-Tax Income
7.07 -2.18 -10 2.61 -8.14 -23 -18 -4.73 -12 2.51 -4.71
Total Operating Income
6.79 -2.83 -11 2.39 -8.15 -23 -18 -4.59 -12 2.71 -4.65
Total Gross Profit
63 70 34 47 38 45 23 35 26 41 29
Total Revenue
115 133 68 94 70 100 52 71 62 85 56
Operating Revenue
115 133 68 94 70 100 52 71 62 85 56
Total Cost of Revenue
52 64 34 47 32 55 29 35 36 44 27
Operating Cost of Revenue
52 64 34 47 32 55 29 35 36 44 27
Total Operating Expenses
56 72 45 44 47 68 41 40 38 38 33
Selling, General & Admin Expense
56 67 45 44 47 62 41 40 39 38 34
Other Operating Expenses / (Income)
-0.14 -0.14 -0.44 -0.13 -0.13 -0.13 -0.18 -0.35 -0.31 -0.35 -0.65
Total Other Income / (Expense), net
0.29 0.65 0.47 0.22 0.02 0.06 0.00 -0.13 -0.14 -0.20 -0.07
Interest & Investment Income
0.29 - 0.47 0.22 0.02 - 0.00 -0.13 -0.14 - -0.07
Income Tax Expense
1.95 -0.33 -2.54 -4.92 5.19 24 0.41 -0.02 0.06 -0.14 0.11
Net Income / (Loss) Discontinued Operations
- - - - 0.53 - - 0.04 0.00 - 0.00
Basic Earnings per Share
$0.17 ($0.07) ($0.26) $0.19 ($0.46) ($1.62) ($1.20) ($0.17) ($0.44) $0.10 ($0.17)
Weighted Average Basic Shares Outstanding
30.81M 30.83M 30.66M 29.29M 28.07M 28.94M 27.77M 27.94M 27.94M 27.90M 28.12M
Diluted Earnings per Share
$0.16 ($0.06) ($0.26) $0.19 ($0.46) ($1.62) ($1.20) ($0.17) ($0.44) $0.10 ($0.17)
Weighted Average Diluted Shares Outstanding
31.32M 31.31M 30.66M 29.82M 28.07M 28.94M 27.77M 27.94M 27.94M 27.90M 28.12M
Weighted Average Basic & Diluted Shares Outstanding
30.83M 30.79M 29.49M 28.23M 27.73M 27.70M 27.93M 27.94M 27.96M 27.97M 28.44M

Annual Cash Flow Statements for Vera Bradley

This table details how cash moves in and out of Vera Bradley's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Net Change in Cash & Equivalents
-15 -11 -18 45 -64 14 24 -42 31 -47 -12
Net Cash From Operating Activities
43 65 43 44 21 21 40 -13 48 -14 -9.97
Net Cash From Continuing Operating Activities
43 65 43 44 21 21 40 -13 48 -14 -9.97
Net Income / (Loss) Continuing Operations
28 20 7.02 21 15 11 20 -79 7.84 -62 -48
Consolidated Net Income / (Loss)
28 20 7.02 21 15 11 20 -79 7.84 -62 -48
Depreciation Expense
19 20 20 17 18 13 9.32 8.85 7.97 8.53 7.77
Amortization Expense
- - 0.00 0.00 27 30 24 25 24 22 20
Non-Cash Adjustments To Reconcile Net Income
8.44 17 10 4.16 14 14 5.08 74 8.70 13 17
Changes in Operating Assets and Liabilities, net
-12 8.87 6.00 2.11 -55 -48 -18 -42 -0.45 5.25 -7.42
Net Cash From Investing Activities
-26 -51 -52 18 -70 18 -4.15 -8.24 -14 -10 -1.54
Net Cash From Continuing Investing Activities
-26 -51 -52 18 -70 18 -4.15 -8.24 -14 -10 -1.54
Purchase of Property, Plant & Equipment
-26 -21 -12 -8.15 -13 -5.74 -5.49 -8.24 -3.77 -10 -3.29
Acquisitions
- - 0.00 0.00 -76 0.99 0.00 0.00 -10 0.00 0.00
Divestitures
- - - - - - - - 0.00 0.00 1.75
Net Cash From Financing Activities
-32 -26 -8.65 -17 -14 -24 -11 -20 -3.55 -23 -0.23
Net Cash From Continuing Financing Activities
-32 -26 -8.65 -17 -14 -24 -11 -20 -3.55 -23 -0.23
Repayment of Debt
-0.08 -0.03 -0.12 -0.16 0.00 -60 - - 0.00 0.00 -15
Repurchase of Common Equity
-31 -25 -7.91 -16 -11 -3.08 -7.74 -18 -2.19 -22 0.00
Issuance of Debt
- - - 0.00 0.00 60 - - 0.00 0.00 15
Other Financing Activities, net
-0.58 -0.73 -0.62 -0.55 -1.16 -19 -2.46 -1.43 -1.36 -0.75 -0.23
Effect of Exchange Rate Changes
-0.03 -0.01 -0.01 -0.01 0.05 0.02 -0.03 -0.08 0.03 0.05 -0.11
Cash Interest Paid
0.26 0.25 0.19 0.17 0.12 1.13 0.29 0.09 0.15 0.14 0.36
Cash Income Taxes Paid
9.30 25 1.94 4.04 6.49 5.08 9.08 -6.57 0.84 1.35 0.07

Quarterly Cash Flow Statements for Vera Bradley

This table details how cash moves in and out of Vera Bradley's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
Net Change in Cash & Equivalents
3.74 25 -22 -11 -30 17 -19 3.90 -4.46 7.78 -6.01
Net Cash From Operating Activities
5.08 27 -15 1.40 -23 22 -18 -5.40 -4.00 17 -5.25
Net Cash From Continuing Operating Activities
5.08 27 -15 1.40 -23 22 -18 -5.40 -4.00 17 -5.25
Net Income / (Loss) Continuing Operations
5.12 -1.86 -8.12 5.71 -13 -47 -33 -4.67 -12 2.66 -4.83
Consolidated Net Income / (Loss)
5.12 -1.86 -8.12 5.71 -13 -47 -33 -4.67 -12 2.66 -4.83
Depreciation Expense
1.92 1.98 1.94 1.91 2.37 2.32 2.19 1.91 1.83 1.84 1.79
Amortization Expense
5.85 6.13 5.42 5.25 5.52 5.58 5.33 4.89 4.98 5.03 4.93
Non-Cash Adjustments To Reconcile Net Income
0.84 6.20 0.85 0.57 3.06 8.06 17 -0.72 0.04 0.96 1.05
Changes in Operating Assets and Liabilities, net
-8.65 14 -15 -12 -21 53 -8.97 -6.81 1.51 6.85 -8.19
Net Cash From Investing Activities
-0.82 -1.22 -0.86 -2.79 -2.40 -4.32 -0.97 -0.61 -0.45 0.49 -0.33
Net Cash From Continuing Investing Activities
-0.82 -1.22 -0.86 -2.79 -2.40 -4.32 -0.97 -0.61 -0.45 0.49 -0.33
Purchase of Property, Plant & Equipment
-0.82 -1.22 -0.86 -2.79 -2.40 -4.32 -1.87 -0.74 -0.45 -0.23 -0.33
Divestitures
- - 0.00 - - - 0.90 0.13 - 0.72 0.00
Net Cash From Financing Activities
-0.52 -0.68 -6.70 -9.65 -5.52 -0.64 -0.17 9.97 -0.02 -10 -0.41
Net Cash From Continuing Financing Activities
-0.52 -0.68 -6.70 -9.65 -5.52 -0.64 -0.17 9.97 -0.02 -10 -0.41
Repayment of Debt
- - 0.00 - - - -5.00 - - -10 0.00
Issuance of Debt
- - 0.00 - - - 5.00 10 - - 0.00
Other Financing Activities, net
-0.03 -0.38 -0.36 -0.11 -0.23 -0.06 -0.17 -0.03 -0.02 -0.02 -0.41
Effect of Exchange Rate Changes
-0.01 0.00 0.01 -0.01 0.09 -0.03 -0.04 -0.06 0.02 -0.02 -0.01
Cash Interest Paid
- - 0.00 - - - 0.02 0.10 0.10 0.14 0.05
Cash Income Taxes Paid
0.09 0.09 0.92 0.24 0.15 0.04 0.09 0.17 - -0.19 -0.01

Annual Balance Sheets for Vera Bradley

This table presents Vera Bradley's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
Total Assets
381 374 351 362 535 514 518 405 381 307 234
Total Current Assets
254 256 242 252 219 260 279 227 226 165 120
Cash & Equivalents
98 86 69 113 50 64 88 47 77 29 19
Accounts Receivable
31 23 16 16 24 28 21 22 17 14 17
Inventories, net
114 102 88 92 124 141 145 142 118 91 76
Current Deferred & Refundable Income Taxes
0.79 3.22 4.39 0.81 1.04 7.37 9.39 1.31 0.46 0.58 0.32
Other Current Assets
10 10 11 12 - - - - - 0.00 7.64
Plant, Property, & Equipment, net
114 102 86 78 73 64 60 59 54 53 46
Total Noncurrent Assets
13 16 22 32 243 190 178 119 101 89 68
Other Noncurrent Operating Assets
1.96 2.82 1.28 1.27 120 95 86 82 73 84 68
Total Liabilities & Shareholders' Equity
381 374 351 362 535 514 518 405 381 307 234
Total Liabilities
95 90 65 67 201 169 159 142 121 128 102
Total Current Liabilities
67 63 40 44 87 77 78 68 58 58 50
Accounts Payable
25 33 14 15 20 27 30 20 14 17 16
Accrued Expenses
17 17 12 13 14 14 16 13 12 9.22 10
Current Deferred & Payable Income Tax Liabilities
10 0.51 0.81 2.16 2.11 0.32 0.00 0.56 0.64 0.00 0.02
Current Employee Benefit Liabilities
15 12 14 13 11 14 12 14 13 6.53 5.39
Other Current Liabilities
- - - 0.00 40 22 19 20 18 19 19
Total Noncurrent Liabilities
29 27 25 24 114 92 81 75 63 70 52
Other Noncurrent Operating Liabilities
29 27 25 24 114 92 81 75 63 66 52
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
285 284 285 295 304 315 327 251 260 179 132
Total Preferred & Common Equity
285 284 285 295 304 315 327 251 260 179 132
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
285 284 285 295 304 315 327 251 260 179 132
Common Stock
85 89 91 96 100 105 108 110 113 116 116
Retained Earnings
244 264 271 292 307 317 334 275 282 220 172
Treasury Stock
-44 -69 -77 -93 -104 -107 -115 -133 -135 -157 -157
Accumulated Other Comprehensive Income / (Loss)
-0.04 -0.05 -0.11 -0.02 0.16 0.01 -0.03 -0.11 -0.07 -0.02 -0.13

Quarterly Balance Sheets for Vera Bradley

This table presents Vera Bradley's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 7/29/2023 10/28/2023 5/4/2024 8/3/2024 11/2/2024 5/3/2025 8/2/2025 11/1/2025 5/2/2026
Total Assets
392 383 369 379 359 268 266 244 219
Total Current Assets
229 221 218 223 185 136 140 122 111
Cash & Equivalents
49 52 55 44 14 11 15 11 13
Accounts Receivable
24 26 18 25 24 15 17 19 17
Inventories, net
139 129 125 133 131 99 97 83 73
Current Deferred & Refundable Income Taxes
2.18 1.38 3.86 6.43 3.95 0.32 0.44 0.39 0.31
Other Current Assets
15 13 16 15 12 10 11 9.31 8.34
Plant, Property, & Equipment, net
56 56 53 56 54 51 49 48 45
Total Noncurrent Assets
107 106 97 100 120 81 76 73 63
Other Noncurrent Operating Assets
72 73 70 73 93 81 76 73 63
Total Liabilities & Shareholders' Equity
392 383 369 379 359 268 266 244 219
Total Liabilities
135 121 123 137 134 122 126 116 92
Total Current Liabilities
68 57 63 78 60 60 58 49 45
Accounts Payable
22 12 22 38 20 23 21 15 9.19
Accrued Expenses
13 14 14 16 12 12 12 8.48 10
Current Deferred & Payable Income Tax Liabilities
0.53 0.57 0.00 0.17 0.21 0.06 - - 0.13
Current Employee Benefit Liabilities
13 12 9.07 6.62 6.88 6.03 7.24 6.01 7.50
Other Current Liabilities
20 19 18 18 21 19 18 19 18
Total Noncurrent Liabilities
67 64 60 58 74 62 68 67 47
Other Noncurrent Operating Liabilities
67 64 60 58 74 62 58 57 47
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
257 262 246 243 225 146 140 128 127
Total Preferred & Common Equity
257 262 246 243 225 146 140 128 127
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
257 262 246 243 225 146 140 128 127
Common Stock
112 112 113 114 114 116 115 115 116
Retained Earnings
279 284 274 280 267 187 182 170 168
Treasury Stock
-134 -135 -141 -151 -156 -157 -157 -157 -157
Accumulated Other Comprehensive Income / (Loss)
-0.07 -0.07 -0.06 -0.07 0.01 -0.06 -0.13 -0.11 -0.14

Annual Metrics And Ratios for Vera Bradley

This table displays calculated financial ratios and metrics derived from Vera Bradley's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/30/2016 1/28/2017 2/3/2018 2/2/2019 2/1/2020 1/30/2021 1/29/2022 1/28/2023 2/3/2024 2/1/2025 1/31/2026
DEI Shares Outstanding
37,979,305.00 36,211,077.00 35,482,734.00 34,666,924.00 33,642,427.00 33,414,490.00 33,730,165.00 30,875,844.00 - - 27,955,022.00
DEI Adjusted Shares Outstanding
37,979,305.00 36,211,077.00 35,482,734.00 34,666,924.00 33,642,427.00 33,414,490.00 33,730,165.00 30,875,844.00 - - 27,955,022.00
DEI Earnings Per Adjusted Shares Outstanding
0.73 0.55 0.20 0.60 0.48 0.26 0.53 -1.93 - - -1.71
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-1.26% -3.32% -6.44% -8.48% 19.01% -5.44% 15.41% -7.49% -5.84% -20.99% -15.42%
EBITDA Growth
-16.14% -27.83% -27.62% 26.31% 49.51% -13.13% 5.53% -202.26% 169.23% -128.48% -360.40%
EBIT Growth
-27.08% -39.60% -46.91% 80.90% -28.14% -32.91% 105.98% -452.54% 111.01% -505.63% -10.84%
NOPAT Growth
-32.56% -28.26% -65.66% 191.89% -27.55% -18.47% 73.43% -425.26% 110.88% -510.52% -10.84%
Net Income Growth
-28.33% -28.30% -64.49% 195.85% -26.56% -29.88% 89.15% -492.64% 109.87% -893.42% 2.10%
EPS Growth
-25.26% -25.35% -64.15% 210.53% -20.34% -44.68% 100.00% -465.38% 113.16% -960.00% 20.47%
Operating Cash Flow Growth
-58.32% 50.65% -34.58% 2.16% -52.66% 0.38% 92.55% -133.67% 457.60% -129.38% 29.29%
Free Cash Flow Firm Growth
-81.00% 226.31% -32.29% 5.45% -181.86% -289.18% 132.46% -140.18% 436.15% -89.06% -111.36%
Invested Capital Growth
8.94% -10.83% -12.19% -5.97% 27.47% 58.64% -3.32% -20.18% -15.25% -18.64% -14.30%
Revenue Q/Q Growth
0.29% -3.81% -0.62% -3.21% 8.48% -3.01% 1.35% -0.49% -2.85% -8.22% -16.85%
EBITDA Q/Q Growth
0.60% -30.08% 44.02% -9.16% 11.83% -6.50% -2.72% -2,025.47% 1,120.90% -239.52% 87.59%
EBIT Q/Q Growth
-1.09% -42.38% 272.20% -12.75% 40.29% -38.77% -2.56% -157.62% 128.61% -93.75% 47.34%
NOPAT Q/Q Growth
-5.65% -38.18% 271.04% -0.90% 45.20% -22.51% -14.87% -157.62% 128.26% -93.75% 47.34%
Net Income Q/Q Growth
-5.59% -38.29% 259.06% 0.51% 39.21% -54.61% 38.33% -139.62% 125.36% -264.31% 61.15%
EPS Q/Q Growth
-5.33% -36.14% 280.00% 3.51% 34.29% -33.33% -14.75% -126.19% 141.67% -264.41% 50.15%
Operating Cash Flow Q/Q Growth
-9.09% -6.51% -7.67% -6.82% -9.25% -34.26% 4.12% 16.68% 8.10% -59.85% -76.60%
Free Cash Flow Firm Q/Q Growth
182.70% -10.94% -8.41% -9.45% 77.68% -4,536.25% 6.94% 41.55% -5.33% 125.55% -108.29%
Invested Capital Q/Q Growth
-10.99% -15.42% -13.55% -12.76% -35.65% -2.59% -4.56% -22.35% -12.88% -29.74% -11.16%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
55.95% 56.81% 55.87% 57.34% 54.89% 56.70% 53.28% 47.79% 54.46% 50.23% 46.37%
EBITDA Margin
13.16% 9.82% 7.60% 10.49% 13.18% 12.11% 11.07% -12.24% 9.00% -3.24% -1.45%
Operating Margin
9.30% 5.81% 3.30% 6.51% 3.93% 2.79% 4.98% -18.98% 2.22% -11.39% -11.83%
EBIT Margin
9.30% 5.81% 3.30% 6.51% 3.93% 2.79% 4.98% -18.98% 2.22% -11.39% -11.83%
Profit (Net Income) Margin
5.48% 4.07% 1.54% 4.99% 3.08% 2.28% 3.74% -15.88% 1.66% -16.72% -12.12%
Tax Burden Percent
59.32% 70.46% 45.58% 73.54% 74.15% 90.11% 75.87% 83.54% 69.17% 150.80% 100.94%
Interest Burden Percent
99.44% 99.37% 102.76% 104.15% 105.57% 90.79% 99.02% 100.16% 108.52% 97.36% 101.45%
Effective Tax Rate
40.68% 29.54% 54.42% 26.46% 25.85% 9.89% 24.13% 0.00% 30.83% 0.00% 0.00%
Return on Invested Capital (ROIC)
15.41% 11.21% 4.35% 13.99% 9.19% 5.17% 7.44% -27.36% 3.63% -17.90% -18.23%
ROIC Less NNEP Spread (ROIC-NNEP)
15.56% 11.32% 4.20% 13.43% -5.95% 2.48% 7.69% -8.14% 2.63% 42.54% 13.36%
Return on Net Nonoperating Assets (RNNOA)
-5.73% -4.26% -1.88% -6.83% 0.19% 0.53% -1.68% 1.77% -0.63% -10.44% -2.82%
Return on Equity (ROE)
9.67% 6.94% 2.47% 7.16% 9.39% 5.70% 5.75% -25.59% 3.00% -28.34% -21.04%
Cash Return on Invested Capital (CROIC)
6.85% 22.66% 17.33% 20.15% -14.96% -40.17% 10.81% -4.91% 20.14% 2.65% -2.82%
Operating Return on Assets (OROA)
12.33% 7.48% 4.14% 7.60% 4.34% 2.49% 5.22% -20.58% 2.66% -12.32% -11.80%
Return on Assets (ROA)
7.27% 5.24% 1.94% 5.82% 3.40% 2.04% 3.92% -17.22% 2.00% -18.09% -12.09%
Return on Common Equity (ROCE)
9.67% 6.94% 2.47% 7.16% 8.52% 4.79% 5.25% -23.87% 2.94% -28.34% -21.04%
Return on Equity Simple (ROE_SIMPLE)
9.66% 6.96% 2.46% 7.04% 0.00% 3.39% 6.17% -31.58% 3.02% -34.75% 0.00%
Net Operating Profit after Tax (NOPAT)
28 20 6.83 20 14 12 20 -66 7.22 -30 -22
NOPAT Margin
5.51% 4.09% 1.50% 4.79% 2.92% 2.51% 3.78% -13.28% 1.53% -7.97% -8.28%
Net Nonoperating Expense Percent (NNEP)
-0.15% -0.12% 0.15% 0.56% 15.14% 2.69% -0.26% -19.22% 0.99% -60.44% -31.59%
Return On Investment Capital (ROIC_SIMPLE)
- - - 6.76% - - - -26.42% 2.78% -16.57% -16.97%
Cost of Revenue to Revenue
44.05% 43.19% 44.13% 42.66% 45.11% 43.30% 46.72% 52.21% 45.54% 49.77% 53.63%
SG&A Expenses to Revenue
47.12% 51.27% 52.75% 50.95% 51.18% 53.94% 48.48% 53.01% 51.29% 60.17% 58.65%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
46.65% 51.00% 52.57% 50.83% 50.95% 53.91% 48.30% 66.77% 52.25% 61.62% 58.20%
Earnings before Interest and Taxes (EBIT)
47 28 15 27 19 13 27 -95 10 -42 -32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
66 48 35 44 65 57 60 -61 42 -12 -3.92
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.97 1.48 1.16 1.04 1.06 0.90 0.81 0.68 0.93 0.58 0.51
Price to Tangible Book Value (P/TBV)
1.97 1.48 1.16 1.04 1.59 1.26 1.12 0.73 0.96 0.58 0.51
Price to Revenue (P/Rev)
1.12 0.86 0.73 0.74 0.65 0.60 0.49 0.34 0.51 0.28 0.25
Price to Earnings (P/E)
20.37 21.26 47.19 14.80 20.08 32.53 14.96 0.00 30.83 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.91% 4.70% 2.12% 6.76% 4.98% 3.07% 6.69% 0.00% 3.24% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.47 1.81 1.31 1.09 1.58 0.88 0.78 0.63 0.90 0.49 0.43
Enterprise Value to Revenue (EV/Rev)
0.92 0.62 0.42 0.36 0.56 0.53 0.39 0.27 0.35 0.20 0.18
Enterprise Value to EBITDA (EV/EBITDA)
7.01 6.36 5.58 3.45 4.27 4.35 3.50 0.00 3.88 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
9.92 10.75 12.86 5.55 14.30 18.88 7.78 0.00 15.74 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
16.73 15.26 28.22 7.55 19.29 20.95 10.25 0.00 22.76 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
10.72 4.66 4.52 3.46 13.51 11.92 5.25 0.00 3.43 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
37.64 7.55 7.08 5.24 0.00 0.00 7.05 0.00 4.10 16.71 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.37 -0.38 -0.45 -0.51 -0.03 0.21 -0.22 -0.22 -0.24 -0.25 -0.21
Leverage Ratio
1.33 1.33 1.27 1.23 2.76 2.80 1.47 1.49 1.50 1.57 1.74
Compound Leverage Factor
1.32 1.32 1.31 1.28 2.92 2.54 1.45 1.49 1.63 1.53 1.77
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 100.00% 8.65% 8.64% 4.09% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 0.00% 91.35% 91.36% 95.91% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
6.74 5.97 6.25 5.95 3.11 3.29 3.59 2.61 4.09 2.67 2.48
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 9.25% 15.97% 8.64% 6.72% 2.05% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.81 4.09 6.01 5.80 2.50 3.35 3.58 3.35 3.88 2.84 2.37
Quick Ratio
1.94 2.24 3.44 3.41 0.95 1.20 1.40 1.02 1.62 0.78 0.71
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
12 40 27 29 -23 -91 30 -12 40 4.39 -3.46
Operating Cash Flow to CapEx
164.39% 313.85% 361.68% 534.99% 154.87% 360.47% 732.20% -162.90% 1,273.02% -135.95% -303.07%
Free Cash Flow to Firm to Interest Expense
46.84 225.83 0.00 0.00 0.00 -76.01 112.87 -77.95 0.00 0.00 -7.49
Operating Cash Flow to Interest Expense
164.52 366.21 0.00 0.00 0.00 17.21 151.56 -87.72 0.00 0.00 -21.58
Operating Cash Flow Less CapEx to Interest Expense
64.44 249.53 0.00 0.00 0.00 12.43 130.86 -141.57 0.00 0.00 -28.70
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.33 1.29 1.26 1.17 1.10 0.89 1.05 1.08 1.20 1.08 1.00
Accounts Receivable Turnover
16.04 17.80 23.39 26.70 24.83 18.07 22.41 23.37 24.01 23.32 17.34
Inventory Turnover
2.09 1.94 2.11 1.98 2.08 1.53 1.76 1.82 1.65 1.62 1.73
Fixed Asset Turnover
4.51 4.51 4.84 5.06 0.00 0.00 8.72 8.43 8.34 6.86 5.45
Accounts Payable Turnover
7.70 7.34 8.70 12.64 12.83 8.57 8.77 10.27 12.43 10.91 8.65
Days Sales Outstanding (DSO)
22.76 20.51 15.61 13.67 14.70 20.20 16.28 15.62 15.20 15.65 21.05
Days Inventory Outstanding (DIO)
174.74 187.70 172.93 184.46 175.78 238.55 206.92 200.78 221.81 225.05 211.23
Days Payable Outstanding (DPO)
47.41 49.76 41.95 28.89 28.45 42.60 41.62 35.55 29.37 33.46 42.19
Cash Conversion Cycle (CCC)
150.09 158.45 146.59 169.25 162.03 216.15 181.58 180.85 207.64 207.24 190.09
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
188 167 147 138 176 279 270 215 183 149 113
Invested Capital Turnover
2.79 2.74 2.89 2.92 3.15 2.06 1.97 2.06 2.37 2.25 2.20
Increase / (Decrease) in Invested Capital
15 -20 -20 -8.77 38 103 -9.27 -54 -33 -34 -19
Enterprise Value (EV)
464 303 193 151 279 247 209 135 164 73 49
Market Capitalization
561 420 331 307 322 282 267 171 242 104 67
Book Value per Share
$7.51 $7.84 $8.04 $8.50 $0.00 $9.42 $9.71 $8.14 $8.43 $6.45 $4.71
Tangible Book Value per Share
$7.51 $7.84 $8.04 $8.50 $0.00 $6.68 $7.08 $7.63 $8.19 $6.45 $4.71
Total Capital
285 284 285 295 30 345 358 262 260 179 132
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-98 -117 -138 -157 -74 -65 -88 -47 -77 -30 -19
Capital Expenditures (CapEx)
26 21 12 8.14 13 5.74 5.44 8.24 3.77 10 3.29
Debt-free, Cash-free Net Working Capital (DFCFNWC)
89 76 79 76 72 117 113 112 90 77 51
Debt-free Net Working Capital (DFNWC)
187 193 202 209 131 182 201 159 168 107 69
Net Working Capital (NWC)
187 193 202 209 131 182 201 159 168 107 69
Net Nonoperating Expense (NNE)
0.16 0.13 -0.19 -0.83 -0.80 1.08 0.20 13 -0.62 33 10
Net Nonoperating Obligations (NNO)
-98 -117 -138 -157 146 -65 -88 -47 -77 -30 -19
Total Depreciation and Amortization (D&A)
19 20 20 17 46 44 33 34 32 30 28
Debt-free, Cash-free Net Working Capital to Revenue
17.79% 15.74% 17.34% 18.27% 14.64% 24.94% 20.87% 22.46% 19.20% 20.57% 18.82%
Debt-free Net Working Capital to Revenue
37.22% 39.73% 44.37% 50.21% 26.53% 38.92% 37.24% 31.78% 35.62% 28.73% 25.69%
Net Working Capital to Revenue
37.22% 39.73% 44.37% 50.21% 26.53% 38.92% 37.24% 31.78% 35.62% 28.73% 25.69%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.71 $0.54 $0.20 $0.59 $0.47 $0.26 $0.53 ($1.90) $0.25 ($2.15) ($1.71)
Adjusted Weighted Average Basic Shares Outstanding
38.80M 36.84M 35.93M 35.22M 33.98M 33.39M 33.79M 31.50M 30.83M 28.94M 27.90M
Adjusted Diluted Earnings per Share
$0.71 $0.53 $0.19 $0.59 $0.47 $0.26 $0.52 ($1.90) $0.25 ($2.15) ($1.71)
Adjusted Weighted Average Diluted Shares Outstanding
38.86M 36.97M 36.03M 35.47M 34.29M 33.91M 34.44M 31.50M 31.31M 28.94M 27.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
34.87M 36.18M 35.52M 34.16M 33.12M 33.41M 32.52M 30.69M 30.79M 27.70M 27.97M
Normalized Net Operating Profit after Tax (NOPAT)
28 20 10 20 14 12 20 -18 11 -25 -22
Normalized NOPAT Margin
5.51% 4.09% 2.31% 4.79% 2.92% 2.51% 3.78% -3.59% 2.33% -6.80% -8.28%
Pre Tax Income Margin
9.24% 5.77% 3.39% 6.78% 4.15% 2.53% 4.93% -19.01% 2.41% -11.09% -12.01%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
177.65 158.54 0.00 0.00 0.00 10.86 102.32 -620.07 0.00 0.00 -69.07
NOPAT to Interest Expense
105.38 111.70 0.00 0.00 0.00 9.79 77.63 -434.05 0.00 0.00 -48.35
EBIT Less CapEx to Interest Expense
77.57 41.85 0.00 0.00 0.00 6.09 81.62 -673.92 0.00 0.00 -76.19
NOPAT Less CapEx to Interest Expense
5.29 -4.98 0.00 0.00 0.00 5.01 56.93 -487.90 0.00 0.00 -55.47
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 11.74% 17.00% 6.01% -0.77% 0.00% 0.00% 0.00%
Augmented Payout Ratio
112.02% 126.32% 112.71% 77.39% 86.13% 45.79% 44.30% -23.52% 27.97% -35.00% 0.00%

Quarterly Metrics And Ratios for Vera Bradley

This table displays calculated financial ratios and metrics derived from Vera Bradley's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/28/2023 2/3/2024 5/4/2024 8/3/2024 11/2/2024 2/1/2025 5/3/2025 8/2/2025 11/1/2025 1/31/2026 5/2/2026
DEI Shares Outstanding
30,822,993.00 - - - - - 27,700,900.00 27,933,384.00 27,936,522.00 27,955,022.00 27,965,338.00
DEI Adjusted Shares Outstanding
30,822,993.00 - - - - - 27,700,900.00 27,933,384.00 27,936,522.00 27,955,022.00 27,965,338.00
DEI Earnings Per Adjusted Shares Outstanding
0.17 - - - - - -1.21 -0.17 -0.44 0.10 -0.17
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-7.30% -9.40% -14.58% -13.54% -29.92% -24.99% -23.98% -24.62% -11.68% -1.71% 7.84%
EBITDA Growth
-0.11% 112.81% -330.34% -51.63% -117.82% -392.16% -216.82% -76.85% -1,872.79% 312.14% 120.08%
EBIT Growth
13.90% 94.32% -78.99% -77.69% -254.35% -724.46% -68.19% -291.89% -49.32% 121.84% 73.97%
NOPAT Growth
1.05% 94.32% -78.99% -44.97% -249.27% -724.46% -68.19% -146.61% -49.32% 132.97% 73.97%
Net Income Growth
5.98% 95.43% -73.56% -38.34% -350.10% -2,432.24% -140.14% -162.56% 7.25% 113.31% 73.58%
EPS Growth
-5.88% 93.41% -73.33% -36.67% -387.50% -2,600.00% -361.54% -189.47% 4.35% 106.17% 85.83%
Operating Cash Flow Growth
152.73% 15.42% -66.18% -94.35% -544.74% -19.60% -23.05% -485.98% 82.29% -19.97% 70.67%
Free Cash Flow Firm Growth
611.41% 57.27% -54.22% -75.72% -112.64% -42.66% 84.96% 262.72% 1,097.89% -48.15% -60.99%
Invested Capital Growth
-24.47% -15.25% -13.96% -4.62% 0.89% -18.64% -29.35% -31.80% -39.79% -14.30% -15.00%
Revenue Q/Q Growth
-10.29% 15.90% -39.52% 37.49% -27.29% 24.06% -40.19% 37.18% -12.14% 36.36% -34.38%
EBITDA Q/Q Growth
-29.84% -63.73% -177.23% 346.11% -125.84% -494.79% -129.09% 121.39% -342.59% 278.46% -78.32%
EBIT Q/Q Growth
-47.28% -141.69% -304.03% 125.13% -464.69% -122.68% -43.83% 74.28% -165.11% 122.27% -271.45%
NOPAT Q/Q Growth
-46.97% -140.32% -304.03% 163.71% -243.84% -122.68% -43.83% 74.28% -165.11% 133.62% -213.56%
Net Income Q/Q Growth
-44.69% -136.24% -337.79% 170.26% -324.33% -266.98% 8.56% 74.21% -162.58% 121.49% -281.60%
EPS Q/Q Growth
-46.67% -137.50% -333.33% 173.08% -342.11% -252.17% 25.93% 85.83% -158.82% 122.73% -270.00%
Operating Cash Flow Q/Q Growth
-79.45% 429.90% -154.02% 109.61% -1,717.02% 195.79% -182.67% 69.86% 25.82% 532.93% -130.29%
Free Cash Flow Firm Q/Q Growth
20.18% -57.58% -25.76% -35.87% -162.58% 292.42% 3.66% 37.73% 26.32% -71.25% -22.01%
Invested Capital Q/Q Growth
0.78% -12.88% 4.43% 4.02% 6.60% -29.74% 2.08% 0.41% -5.89% -11.16% 1.25%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
54.79% 52.26% 51.99% 50.86% 54.12% 44.98% 44.08% 50.10% 42.06% 47.81% 51.76%
EBITDA Margin
12.66% 3.96% -5.06% 9.05% -3.22% -15.43% -20.02% 3.12% -8.62% 11.28% 3.73%
Operating Margin
5.90% -2.12% -14.18% 2.59% -13.00% -23.33% -34.57% -6.48% -19.56% 3.19% -8.34%
EBIT Margin
5.90% -2.12% -14.18% 2.59% -13.00% -23.33% -34.57% -6.48% -19.56% 3.19% -8.34%
Profit (Net Income) Margin
4.45% -1.39% -10.08% 5.15% -15.89% -46.99% -35.35% -6.65% -19.86% 3.13% -8.66%
Tax Burden Percent
72.38% 85.09% 75.01% 177.48% 123.54% 201.90% 102.28% 99.64% 100.46% 105.69% 102.38%
Interest Burden Percent
104.20% 77.06% 94.72% 111.94% 98.92% 99.75% 99.98% 102.92% 101.11% 92.73% 101.40%
Effective Tax Rate
27.62% 0.00% 0.00% -77.48% 0.00% 0.00% 0.00% 0.00% 0.00% -5.69% 0.00%
Return on Invested Capital (ROIC)
8.50% -3.51% -22.00% 9.95% -17.51% -36.68% -44.98% -9.04% -26.20% 7.43% -12.83%
ROIC Less NNEP Spread (ROIC-NNEP)
7.97% -3.72% -21.70% 8.64% -0.94% 20.24% -27.65% -2.98% 27.03% 8.06% 0.39%
Return on Net Nonoperating Assets (RNNOA)
-1.09% 0.88% 3.55% -1.60% 0.13% -4.97% 4.69% 0.38% -1.10% -1.70% -0.03%
Return on Equity (ROE)
7.41% -2.63% -18.46% 8.35% -17.39% -41.65% -40.29% -8.66% -27.31% 5.73% -12.86%
Cash Return on Invested Capital (CROIC)
17.39% 20.14% 16.66% 3.14% -8.16% 2.65% 18.89% 14.07% 24.63% -2.82% 5.71%
Operating Return on Assets (OROA)
6.78% -2.55% -17.31% 2.96% -14.20% -25.25% -32.85% -6.68% -21.05% 3.19% -9.38%
Return on Assets (ROA)
5.11% -1.67% -12.30% 5.87% -17.36% -50.85% -33.60% -6.85% -21.38% 3.12% -9.73%
Return on Common Equity (ROCE)
7.10% -2.58% -18.46% 8.35% -17.39% -41.65% -40.29% -8.66% -27.31% 5.73% -12.86%
Return on Equity Simple (ROE_SIMPLE)
-11.80% 0.00% 1.79% 0.35% -7.58% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
4.91 -1.98 -8.00 5.10 -7.33 -16 -12 -3.21 -8.52 2.87 -3.25
NOPAT Margin
4.27% -1.49% -9.93% 4.60% -9.10% -16.33% -24.20% -4.54% -13.69% 3.38% -5.84%
Net Nonoperating Expense Percent (NNEP)
0.53% 0.20% -0.30% 1.31% -16.58% -56.93% -17.33% -6.06% -53.23% -0.64% -13.21%
Return On Investment Capital (ROIC_SIMPLE)
1.88% -0.76% - - -3.26% -9.12% -8.56% -2.14% -6.17% 2.18% -2.56%
Cost of Revenue to Revenue
45.21% 47.74% 48.01% 49.14% 45.88% 55.02% 55.92% 49.90% 57.94% 52.19% 48.24%
SG&A Expenses to Revenue
49.02% 50.41% 66.72% 48.39% 67.29% 62.20% 79.00% 57.07% 62.12% 45.03% 61.27%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
48.89% 54.38% 66.18% 48.27% 67.12% 68.31% 78.65% 56.58% 61.62% 44.62% 60.10%
Earnings before Interest and Taxes (EBIT)
6.79 -2.83 -11 2.87 -10 -23 -18 -4.59 -12 2.71 -4.65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
15 5.28 -4.08 10 -2.59 -15 -10 2.21 -5.37 9.58 2.08
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.85 0.93 0.86 0.74 0.63 0.58 0.38 0.39 0.51 0.51 0.91
Price to Tangible Book Value (P/TBV)
0.89 0.96 0.88 0.76 0.65 0.58 0.38 0.39 0.51 0.51 0.91
Price to Revenue (P/Rev)
0.46 0.51 0.46 0.41 0.35 0.28 0.18 0.16 0.20 0.25 0.42
Price to Earnings (P/E)
0.00 30.83 47.91 211.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 3.24% 2.09% 0.47% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.81 0.90 0.81 0.68 0.61 0.49 0.32 0.36 0.51 0.43 0.90
Enterprise Value to Revenue (EV/Rev)
0.35 0.35 0.34 0.31 0.32 0.20 0.14 0.15 0.20 0.18 0.38
Enterprise Value to EBITDA (EV/EBITDA)
0.00 3.88 4.26 5.24 14.87 0.00 0.00 0.00 0.00 0.00 12.12
Enterprise Value to EBIT (EV/EBIT)
0.00 15.74 28.79 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 22.76 45.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
3.81 3.43 3.68 7.16 0.00 0.00 0.00 0.00 0.00 0.00 38.42
Enterprise Value to Free Cash Flow (EV/FCFF)
4.00 4.10 4.52 21.15 0.00 16.71 1.42 2.09 1.56 0.00 14.47
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.08 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.08 0.00 0.00
Financial Leverage
-0.14 -0.24 -0.16 -0.19 -0.14 -0.25 -0.17 -0.13 -0.04 -0.21 -0.09
Leverage Ratio
1.50 1.50 1.52 1.54 1.52 1.57 1.62 1.69 1.71 1.74 1.78
Compound Leverage Factor
1.56 1.16 1.44 1.73 1.51 1.56 1.62 1.73 1.72 1.61 1.81
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.65% 7.24% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.65% 7.24% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 93.35% 92.76% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 -0.32 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.02 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 -0.32 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.25 -0.24 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.02 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.25 -0.24 0.00 0.00
Altman Z-Score
3.98 3.98 3.71 3.46 3.13 2.87 2.50 2.78 2.85 2.97 3.36
Noncontrolling Interest Sharing Ratio
4.10% 2.05% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.89 3.88 3.47 2.85 3.09 2.84 2.28 2.43 2.52 2.37 2.48
Quick Ratio
1.37 1.62 1.16 0.88 0.64 0.78 0.43 0.56 0.61 0.71 0.66
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
73 31 23 15 -9.20 18 43 60 76 22 17
Operating Cash Flow to CapEx
620.63% 2,200.57% -1,685.86% 50.18% -941.52% 500.93% -956.81% -727.22% -885.62% 7,702.22% -1,576.58%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.15 1.20 1.22 1.14 1.09 1.08 0.95 1.03 1.08 1.00 1.12
Accounts Receivable Turnover
19.11 24.01 23.98 17.92 16.26 23.32 18.64 15.79 15.00 17.34 17.17
Inventory Turnover
1.55 1.65 1.57 1.53 1.49 1.62 1.38 1.46 1.61 1.73 1.66
Fixed Asset Turnover
8.33 8.34 8.24 7.84 7.35 6.86 5.80 6.31 6.34 5.45 5.70
Accounts Payable Turnover
10.95 12.43 11.00 7.01 12.02 10.91 6.89 5.69 9.95 8.65 8.80
Days Sales Outstanding (DSO)
19.10 15.20 15.22 20.37 22.45 15.65 19.58 23.11 24.33 21.05 21.26
Days Inventory Outstanding (DIO)
235.97 221.81 232.33 238.09 245.33 225.05 264.24 249.30 227.10 211.23 220.34
Days Payable Outstanding (DPO)
33.32 29.37 33.19 52.06 30.36 33.46 52.95 64.11 36.69 42.19 41.47
Cash Conversion Cycle (CCC)
221.74 207.64 214.37 206.40 237.43 207.24 230.87 208.31 214.74 190.09 200.13
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
210 183 191 198 211 149 135 135 127 113 115
Invested Capital Turnover
1.99 2.37 2.22 2.16 1.92 2.25 1.86 1.99 1.91 2.20 2.20
Increase / (Decrease) in Invested Capital
-68 -33 -31 -9.61 1.87 -34 -56 -63 -84 -19 -20
Enterprise Value (EV)
169 164 155 135 129 73 44 49 65 49 103
Market Capitalization
222 242 211 179 142 104 55 54 66 67 115
Book Value per Share
$8.50 $8.43 $7.99 $8.22 $7.98 $6.45 $5.27 $5.03 $4.58 $4.71 $4.54
Tangible Book Value per Share
$8.05 $8.19 $7.76 $8.01 $7.76 $6.45 $5.27 $5.03 $4.58 $4.71 $4.54
Total Capital
262 260 246 243 225 179 146 150 138 132 127
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 10 10 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 10 10 0.00 0.00
Net Debt
-52 -77 -55 -44 -14 -30 -11 -5.18 -0.73 -19 -13
Capital Expenditures (CapEx)
0.82 1.22 0.86 2.79 2.40 4.32 1.87 0.74 0.45 0.23 0.33
Debt-free, Cash-free Net Working Capital (DFCFNWC)
112 90 100 101 111 77 65 68 63 51 54
Debt-free Net Working Capital (DFNWC)
164 168 155 145 125 107 76 83 74 69 66
Net Working Capital (NWC)
164 168 155 145 125 107 76 83 74 69 66
Net Nonoperating Expense (NNE)
-0.21 -0.13 0.12 -0.61 5.47 31 5.76 1.49 3.84 0.21 1.57
Net Nonoperating Obligations (NNO)
-52 -77 -55 -44 -14 -30 -11 -5.18 -0.73 -19 -13
Total Depreciation and Amortization (D&A)
7.77 8.11 7.35 7.16 7.88 7.90 7.52 6.80 6.81 6.87 6.72
Debt-free, Cash-free Net Working Capital to Revenue
23.15% 19.20% 21.93% 22.97% 27.47% 20.57% 21.41% 20.31% 19.42% 18.82% 19.72%
Debt-free Net Working Capital to Revenue
33.93% 35.62% 34.01% 33.01% 30.85% 28.73% 25.14% 24.88% 22.73% 25.69% 24.29%
Net Working Capital to Revenue
33.93% 35.62% 34.01% 33.01% 30.85% 28.73% 25.14% 24.88% 22.73% 25.69% 24.29%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.17 ($0.07) ($0.26) $0.19 ($0.46) ($1.62) ($1.20) ($0.17) ($0.44) $0.10 ($0.17)
Adjusted Weighted Average Basic Shares Outstanding
30.81M 30.83M 30.66M 29.29M 28.07M 28.94M 27.77M 27.94M 27.94M 27.90M 28.12M
Adjusted Diluted Earnings per Share
$0.16 ($0.06) ($0.26) $0.19 ($0.46) ($1.62) ($1.20) ($0.17) ($0.44) $0.10 ($0.17)
Adjusted Weighted Average Diluted Shares Outstanding
31.32M 31.31M 30.66M 29.82M 28.07M 28.94M 27.77M 27.94M 27.94M 27.90M 28.12M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
30.83M 30.79M 29.49M 28.23M 27.73M 27.70M 27.93M 27.94M 27.96M 27.97M 28.44M
Normalized Net Operating Profit after Tax (NOPAT)
4.91 -1.98 -8.00 2.01 -7.33 -16 -12 -3.21 -8.52 1.90 -3.25
Normalized NOPAT Margin
4.27% -1.49% -9.93% 1.81% -9.10% -16.33% -24.20% -4.54% -13.69% 2.24% -5.84%
Pre Tax Income Margin
6.15% -1.64% -13.43% 2.90% -12.86% -23.27% -34.56% -6.67% -19.77% 2.96% -8.46%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-8.68% 27.97% 177.62% 1,965.80% -125.78% -35.00% 0.00% -6.90% -0.70% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Vera Bradley’s latest quarter was mixed, but the longer-term trend remains challenging. In Q1 fiscal 2027, revenue fell to $55.7 million from $84.9 million in the prior quarter and $67.9 million a year earlier, while the company posted a net loss of $4.8 million. The good news is that inventory has come down meaningfully from last year’s elevated levels, and the balance sheet still shows positive equity. The bad news is that operating margins remain under pressure, and cash flow turned negative in the latest quarter.

  • Inventory fell to $73.0 million in Q1 2027 from $82.9 million in Q3 2026 and $131.3 million in Q3 2025, suggesting better stock management.
  • Cash and equivalents improved to $12.5 million in Q1 2027 from $10.7 million in Q3 2026, even after a negative quarter of cash generation.
  • Total equity remained solid at $127.0 million in Q1 2027, providing some balance-sheet support.
  • Gross margin was relatively strong in Q1 2027, with gross profit of $28.8 million on $55.7 million of revenue, showing the company can still generate decent product-level profitability.
  • Depreciation and amortization remain significant non-cash add-backs, which helps offset reported losses in cash flow calculations.
  • The company has maintained debt at a modest $10.0 million long-term level in recent quarters, so leverage is not excessive.
  • Revenue declined sharply year over year in Q1 2027, dropping 18.6% from $67.9 million to $55.7 million.
  • Operating income was a loss of $4.6 million in Q1 2027, compared with operating income of $2.7 million in Q4 2026, showing a clear deterioration in near-term profitability.
  • SG&A expense of $34.1 million was greater than gross profit in Q1 2027, meaning overhead still exceeded the company’s gross earnings base.
  • Operating cash flow was negative $5.3 million in Q1 2027, reversing the positive $17.3 million generated in Q4 2026.

Looking at the multi-quarter trend, Vera Bradley’s performance has been volatile but generally weak. Revenue has moved down from $114.99 million in Q3 2024 to $55.70 million in Q1 2027, and earnings have swung from profitability to repeated losses. The company did have a strong rebound in Q4 2026, when revenue rose to $84.9 million and operating cash flow reached $17.3 million, but that improvement did not carry into the latest quarter.

The balance sheet also shows some pressure points. Total liabilities rose to $92.2 million in Q1 2027 from $57.8 million in Q2 2026 and $121.9 million in Q1 2026, while retained earnings have been volatile as losses accumulated and recovered unevenly. Inventory remains much lower than the peak seen in 2025, but it is still large relative to revenue, which could limit flexibility if demand weakens further.

Bottom line: Vera Bradley appears to be stabilizing parts of its balance sheet, but revenue growth, operating leverage, and cash generation are still inconsistent. Investors should watch whether the Q4 2026 improvement was temporary or the start of a more durable turnaround.

07/16/26 03:33 AM ETAI Generated. May Contain Errors.

Vera Bradley Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Vera Bradley's financial year ends in January. Their financial year 2026 ended on January 31, 2026.

Vera Bradley's net income appears to be on an upward trend, with a most recent value of -$32.68 million in 2026, falling from $27.56 million in 2016. The previous period was -$33.38 million in 2025. See Vera Bradley's forecast for analyst expectations on what's next for the company.

Vera Bradley's total operating income in 2026 was -$31.91 million, based on the following breakdown:
  • Total Gross Profit: $125.04 million
  • Total Operating Expenses: $156.95 million

Over the last 10 years, Vera Bradley's total revenue changed from $502.60 million in 2016 to $269.65 million in 2026, a change of -46.3%.

Vera Bradley's total liabilities were at $102.37 million at the end of 2026, a 19.9% decrease from 2025, and a 7.3% increase since 2016.

In the past 10 years, Vera Bradley's cash and equivalents has ranged from $18.51 million in 2026 to $113.49 million in 2019, and is currently $18.51 million as of their latest financial filing in 2026.

Over the last 10 years, Vera Bradley's book value per share changed from 7.51 in 2016 to 4.71 in 2026, a change of -37.3%.



Financial statements for NASDAQ:VRA last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners